No association of prior administration of selected vaccines with lymphoma prognosis.

Authors

George A Cholack, Verena Hinder, Raphael Mwangi, Thomas M Habermann, Dennis P Robinson, Melissa C Larson, Andrew L Feldman, Thomas E Witzig, Stephen M Ansell, Eric Mou, Yucai Wang, Carrie A Thompson, Matthew J Maurer, Anne J Novak, Susan L Slager, James R Cerhan

Published in

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Jun 24, 2026. Epub Jun 24, 2026.

Abstract

While some vaccines appear to be associated with lower risk of lymphoma, their impact on outcomes is largely unknown.
Data from a large prospective lymphoma cohort study was utilized to estimate associations of self-reported history of vaccination against hepatitis A, hepatitis B, influenza, and yellow fever with event-free survival (EFS) and overall survival (OS) using Cox proportional hazard models.
None of the vaccines were associated with EFS (HRs 0.77-1.00) or OS (HRs 0.96-1.04). Similarly, there were no significant associations between the vaccines and outcome for each lymphoma subtype.
Prior vaccination against selected viruses was not associated with EFS or OS among patients with lymphoma.
We did not find evidence for an impact of prior vaccination on lymphoma prognosis.

PMID:
42340351
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.